Peripheral CD4 Loss of Regulatory T Cells is Associated with Persistent Viraemia in Chronic HIV Infection

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 2007 Feb 17

PMID 17302904

Citations 36

Authors

C A R Baker

R Clark

F Ventura

N G Jones

D Guzman

D R Bangsberg

H Cao

Affiliations

Soon will be listed here.

Abstract

Chronic HIV infection is associated with T cell abnormalities and altered effector function. Regulatory T cells (Treg) are CD4+ T cells that play a critical role in regulating the immune system. The impact of regulatory T cells on HIV infection and disease progression may be highly significant. We hypothesize that chronic antigenic stimulation from a persistent, high viraemic state may promote a population of Treg that contributes to HIV-associated immune dysfunction. We evaluated the pattern of Treg in chronically infected, HIV-positive individuals over a course of 6 months. Treg are depleted at a distinct rate from that of absolute CD4 cells and loss of Treg is slower in the presence of viral suppression. In vitro depletion of CD25+ CD4+ cells resulted in increased Gag-specific CD4 and CD8 responses. A significant correlation between ex vivo measurement of Treg and Gag-specific CD4 T cell responses was observed (r=-0 x 41, P=0 x 018) with a trend observed with Gag-specific CD8 T cell responses (P=0 x 07). The impact of HIV infection on the Treg population directly complicates the measured effect of Treg on the immune dysfunction although our data support the important role of Treg on modulating the effector T cell response in chronic infection.

Citing Articles

Early Diagnosis and Monitoring of Adaptive Immune Response in a Cohort of Mild Mpox Patients During the 2022 Wave.

Caldrer S, Accordini S, Donini A, Gianesini N, Matucci A, Mori A Microorganisms. 2025; 13(2).

PMID: 40005722 PMC: 11858686. DOI: 10.3390/microorganisms13020355.

Making a Monkey out of Human Immunodeficiency Virus/Simian Immunodeficiency Virus Pathogenesis: Immune Cell Depletion Experiments as a Tool to Understand the Immune Correlates of Protection and Pathogenicity in HIV Infection.

Symmonds J, Gaufin T, Xu C, Raehtz K, Ribeiro R, Pandrea I Viruses. 2024; 16(6.

PMID: 38932264 PMC: 11209256. DOI: 10.3390/v16060972.

Host Immunity to Mycobacterium tuberculosis Infection Is Similar in Simian Immunodeficiency Virus (SIV)-Infected, Antiretroviral Therapy-Treated and SIV-Naïve Juvenile Macaques.

Larson E, Ellis A, Rodgers M, Gubernat A, Gleim J, Moriarty R Infect Immun. 2023; 91(5):e0055822.

PMID: 37039653 PMC: 10187125. DOI: 10.1128/iai.00558-22.

HIV-1 elite controllers present a high frequency of activated regulatory T and Th17 cells.

Caetano D, de Paula H, Bello G, Hoagland B, Villela L, Grinsztejn B PLoS One. 2020; 15(2):e0228745.

PMID: 32023301 PMC: 7001932. DOI: 10.1371/journal.pone.0228745.

Microbiome Dependent Regulation of T and Th17 Cells in Mucosa.

Pandiyan P, Bhaskaran N, Zou M, Schneider E, Jayaraman S, Huehn J Front Immunol. 2019; 10:426.

PMID: 30906299 PMC: 6419713. DOI: 10.3389/fimmu.2019.00426.

References

Baecher-Allan C, Brown J, Freeman G, Hafler D . CD4+CD25high regulatory cells in human peripheral blood. J Immunol. 2001; 167(3):1245-53. DOI: 10.4049/jimmunol.167.3.1245. View

Liu W, Putnam A, Xu-Yu Z, Szot G, Lee M, Zhu S . CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J Exp Med. 2006; 203(7):1701-11. PMC: 2118339. DOI: 10.1084/jem.20060772. View

Hori S, Carvalho T, Demengeot J . CD25+CD4+ regulatory T cells suppress CD4+ T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur J Immunol. 2002; 32(5):1282-91. DOI: 10.1002/1521-4141(200205)32:5<1282::AID-IMMU1282>3.0.CO;2-#. View

Aseffa A, Gumy A, Launois P, MacDonald H, Louis J, Tacchini-Cottier F . The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells. J Immunol. 2002; 169(6):3232-41. DOI: 10.4049/jimmunol.169.6.3232. View

Montagnoli C, Bacci A, Bozza S, Gaziano R, Mosci P, Sharpe A . B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J Immunol. 2002; 169(11):6298-308. DOI: 10.4049/jimmunol.169.11.6298. View

Belkaid Y, Piccirillo C, Mendez S, Shevach E, Sacks D . CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature. 2002; 420(6915):502-7. DOI: 10.1038/nature01152. View

Sakaguchi S . Regulatory T cells: mediating compromises between host and parasite. Nat Immunol. 2002; 4(1):10-1. DOI: 10.1038/ni0103-10. View

Hori S, Nomura T, Sakaguchi S . Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003; 299(5609):1057-61. DOI: 10.1126/science.1079490. View

Cao D, Malmstrom V, Baecher-Allan C, Hafler D, Klareskog L, Trollmo C . Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol. 2003; 33(1):215-23. DOI: 10.1002/immu.200390024. View

10.

Fontenot J, Gavin M, Rudensky A . Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol. 2003; 4(4):330-6. DOI: 10.1038/ni904. View

11.

Khattri R, Cox T, Yasayko S, Ramsdell F . An essential role for Scurfin in CD4+CD25+ T regulatory cells. Nat Immunol. 2003; 4(4):337-42. DOI: 10.1038/ni909. View

12.

Walker M, Kasprowicz D, Gersuk V, Benard A, Van Landeghen M, Buckner J . Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells. J Clin Invest. 2003; 112(9):1437-43. PMC: 228469. DOI: 10.1172/JCI19441. View

13.

Fu S, Yopp A, Mao X, Chen D, Zhang N, Chen D . CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transplant. 2003; 4(1):65-78. DOI: 10.1046/j.1600-6143.2003.00293.x. View

14.

Aandahl E, Michaelsson J, Moretto W, Hecht F, Nixon D . Human CD4+ CD25+ regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol. 2004; 78(5):2454-9. PMC: 369239. DOI: 10.1128/jvi.78.5.2454-2459.2004. View

15.

Oswald-Richter K, Grill S, Shariat N, Leelawong M, Sundrud M, Haas D . HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells. PLoS Biol. 2004; 2(7):E198. PMC: 449855. DOI: 10.1371/journal.pbio.0020198. View

16.

Kinter A, Hennessey M, Bell A, Kern S, Lin Y, Daucher M . CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med. 2004; 200(3):331-43. PMC: 2211981. DOI: 10.1084/jem.20032069. View

17.

Rouse B, Suvas S . Regulatory cells and infectious agents: detentes cordiale and contraire. J Immunol. 2004; 173(4):2211-5. DOI: 10.4049/jimmunol.173.4.2211. View

18.

Moss A, Hahn J, Perry S, Charlebois E, Guzman D, Clark R . Adherence to highly active antiretroviral therapy in the homeless population in San Francisco: a prospective study. Clin Infect Dis. 2004; 39(8):1190-8. DOI: 10.1086/424008. View

19.

Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carbonneil C, Levy Y . Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells, which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood. 2004; 104(10):3249-56. DOI: 10.1182/blood-2004-01-0365. View

20.

Morgan M, van Bilsen J, Bakker A, Heemskerk B, Schilham M, Hartgers F . Expression of FOXP3 mRNA is not confined to CD4+CD25+ T regulatory cells in humans. Hum Immunol. 2004; 66(1):13-20. DOI: 10.1016/j.humimm.2004.05.016. View